EVALUATION OF FRAGILITY IN PATIENTS WITH NEWLY DIAGONISED MULTIPLE MYELOMA NON-TRANSPLANT CANDIDATES

被引：0
|
作者：
Gonzalez Calle, V [1 ]
Sobejano, E. [1 ]
Higstero, V [1 ]
Presa, D. [1 ]
Ocio, E. [1 ]
Puig, N. [1 ]
Gutierrez, N. [1 ]
Garcia Sanz, R. [1 ]
Mateos, M., V [1 ]
机构：
[1] Hosp Clin Salamanca, Salamanca, Spain
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-022
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] First-line treatment of multiple myeloma in both transplant and non-transplant candidates
    Oriol, Albert
    Abril, Laura
    Ibarra, Gladys
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (07) : 685 - 698
  • [2] Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
    Bobin, Arthur
    Kyheng, Maeva
    Guidez, Stephanie
    Gruchet-Merouze, Cecile
    Richez, Valentine
    Duhamel, Alain
    Karlin, Lionel
    Kolb, Brigitte
    Tiab, Mourad
    Araujo, Carla
    Meuleman, Nathalie
    Malfuson, Jean-Valere
    Bourquard, Pascal
    Lenain, Pascal
    Perrot, Aurore
    Roussel, Murielle
    Jaccard, Arnaud
    Petillon, Marie-Odile
    Belhadj-Merzoug, Karim
    Chretien, Marie-Lorraine
    Fontan, Jean
    Rodon, Philippe
    Schmitt, Anna
    Offner, Fritz
    Voillat, Laurent
    Cereja, Sophie
    Kuhnowski, Frederique
    Rigaudeau, Sophie
    Decaux, Olivier
    Humbrecht-Kraut, Catherine
    Frayfer, Jamile
    Fitoussi, Olivier
    Roos-Weil, Damien
    Eisenmann, Jean Claude
    Dorvaux, Veronique
    Voog, Eric G.
    Moreau, Philippe
    Avet-Loiseau, Herve
    Hulin, Cyrille
    Facon, Thierry
    Leleu, Xavier
    LEUKEMIA, 2022, 36 (03) : 881 - 884
  • [3] Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
    Arthur Bobin
    Maéva Kyheng
    Stéphanie Guidez
    Cécile Gruchet-Merouze
    Valentine Richez
    Alain Duhamel
    Lionel Karlin
    Brigitte Kolb
    Mourad Tiab
    Carla Araujo
    Nathalie Meuleman
    Jean-Valère Malfuson
    Pascal Bourquard
    Pascal Lenain
    Aurore Perrot
    Murielle Roussel
    Arnaud Jaccard
    Marie-Odile Petillon
    Karim Belhadj-Merzoug
    Marie-Lorraine Chretien
    Jean Fontan
    Philippe Rodon
    Anna Schmitt
    Fritz Offner
    Laurent Voillat
    Sophie Cereja
    Frédérique Kuhnowski
    Sophie Rigaudeau
    Olivier Decaux
    Catherine Humbrecht-Kraut
    Jamile Frayfer
    Olivier Fitoussi
    Damien Roos-Weil
    Jean Claude Eisenmann
    Véronique Dorvaux
    Eric G. Voog
    Philippe Moreau
    Hervé Avet-Loiseau
    Cyrille Hulin
    Thierry Facon
    Xavier Leleu
    Leukemia, 2022, 36 : 881 - 884
  • [4] Newly diagnosed Multiple Myeloma Daratumumab-Rd - a Standard for non-transplant Eligible Patients
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (06) : 380 - 381
  • [5] EFFECTIVENESS AND DIFFICULTIES OF THE VMP SCHEME (VELCADE-MELPHALAN-PREDNISONE) IN PATIENTS WITH MULTIPLE MYELOMA NON-TRANSPLANT CANDIDATES
    Garzon Lopez, S.
    Gavira, R.
    Salamanca Cuenca, A.
    Jimenez Pichardo, L.
    Verdugo Cabeza de Vaca, V.
    Martin Chacon, E.
    HAEMATOLOGICA, 2017, 102 : 106 - 106
  • [6] The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
    Bobin, Arthur
    Gardeney, Helene
    Sabirou, Florence
    Gruchet, Cecile
    Levy, Anthony
    Nsiala, Laly
    Cailly, Laura
    Tomowiak, Cecile
    Torregrosa, Jose
    Guidez, Stephanie
    Leleu, Xavier
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] EXPERIENCE WITH VTD AS AN INDUCTION TREATMENT TO TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGONISED MULTIPLE MYELOMA
    Gonzalez Fernandez, A.
    Cabrera Ruiz, F. J.
    Revelles Penas, M.
    Garcia Fortes, M.
    Ruiz Arredondo, J. J.
    Heiniger Mazo, A., I
    Garcia Sanchez, R.
    HAEMATOLOGICA, 2017, 102 : 101 - 101
  • [8] Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma
    Gasparet, Cristina
    Gockerman, Jon P.
    Diehl, Louis F.
    De Castro, Carlos, III
    Moore, Joseph
    Long, Gwynn D.
    Horwitz, Mitchell
    Chute, John
    Sullivan, Keith M.
    Netuwirth, Rachel
    Davis, Patricia H.
    Sutton, Linda M.
    Anderson, Russell D.
    Chao, Nelson
    Rizzieri, David A.
    BLOOD, 2008, 112 (11) : 1142 - 1142
  • [9] VTD INDUCTION CHEMOTHERAPY FOLLOWED BY MPT MAINTENANCE AS A FIRST LINE TREATMENT FOR THE PATIENTS WITH MULTIPLE MYELOMA WHO ARE NON-TRANSPLANT CANDIDATES
    Eom, H. S.
    Kim, Y. K.
    Chung, J. S.
    Kim, K. H.
    Kim, H. J.
    Jin, J. Y.
    Do, Y. R.
    Oh, S. J.
    Kim, H. Y.
    Suh, C. W.
    Seong, C. M.
    Kim, C. S.
    Lee, D. S.
    Lee, J. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 88 - 88
  • [10] Outcome of non-transplant eligible patients with newly diagnosed multiple myeloma depending on the eligibility for clinical trials: a single institution experience
    Tovar, Natalia
    Gerardo Rodriguez-Lobato, Luis
    Jimenez, Raquel
    Esteban, Daniel
    Triguero, Ana
    Cibeira, M. T.
    Fernandez De Larrea, C.
    Rosinol, Laura
    Pereira, Arturo
    Blade, J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S128 - S129
12345